Bio-X Interdisciplinary Initiatives Seed Grants Program - Request for Letters of Intent for Interdisciplinary Initiatives (Round 7) - Deadline: April 7, 2014 at 5:00pm PST.
Bio-X Graduate Student Fellowships 2014 - The eleventh annual competition for Bio-X Graduate Student Fellowships - Deadline: March 13, 2014 at 5:00pm PST.
Bio-X Undergraduate Summer Research Program 2014 - The ninth call for applications for the Undergraduate Summer Research Program - Deadline: March 31, 2014 at 5:00pm PST.
The iconic form of Clark Center embodies the collaborative spirit of Bio-X. Sweeping windows reveal open lab spaces which dissolve the walls between labs, people and ideas. Researchers flow through this nexus that blends traditional departments, schools and areas of study.
Visit our timeline to explore highlights of the achievements of Bio-X.
A protein fragment known as beta-amyloid, strongly implicated in Alzheimer’s disease, begins destroying synapses before it clumps into plaques that lead to nerve cell death. This discovery suggests that Alzheimer’s disease starts to manifest long before plaque formation becomes evident.
This cross-discipline research that began with campus newts has led to discovery of a way to highlight the location of pain in a living animal. In the long run, this work, centered in Stanford’s Bio-X program, could also produce a new type of drug for treating pain.
Stanford Bio-X fellow Joel Sadler designed an affordable knee joint for amputees that has impacted thousands of lives. His TEDx talk describes that work, and the creative process that leads to big ideas that change people's lives.
Recordings made by electrodes placed inside the brain can offer incredibly rich data of the electrical signals that occur during both normal and seizure states.
Circulating tumor cells (CTCs) are cancer cells that are shed into the bloodstream by solid tumor masses in a variety of organs; they are often associated with a poor survival rate and may be an important step involved in metastasis.
The most common antiviral tactic involves inhibiting a key process of the virus' biology. Each antiviral, however, is limited to a narrow range of viruses, can quickly develop resistance, and the antivirals are timely and expensive to develop.